← Back to Search

Antiretroviral Therapy Improvement Program for HIV/AIDS (AIMS Trial)

N/A
Waitlist Available
Led By April D Kimmel, PhD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Current age 19-63 years
Identified primary HIV provider for eligible patient participant meeting all selection criteria and with no record of prior ART prescription
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

AIMS Trial Summary

This trial will test a new program to see if it helps people with HIV fill their prescriptions for antiretroviral therapy, and if it improves their health.

Who is the study for?
This trial is for HIV-positive adults aged 19-63 who are on Virginia Medicaid but not Medicare. They must have a primary HIV provider, be continuously enrolled in Medicaid for the past year, and either have late ART prescription refills or no history of ART prescriptions.Check my eligibility
What is being tested?
The study tests a new program's impact on how often patients with HIV fill their antiretroviral therapy (ART) prescriptions and if it improves their health outcomes. It involves both patients and healthcare providers.See study design
What are the potential side effects?
Since this trial focuses on improving prescription refill rates rather than testing new medications, side effects are not the main concern; however, typical ART-related side effects may still occur.

AIMS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 19 and 63 years old.
Select...
I have a primary HIV provider and have never been prescribed ART.
Select...
I am between 19 and 63 years old.
Select...
I have missed my latest ART prescription refill by more than 30 days or have never been on ART.
Select...
I have missed my latest ART prescription refill by more than 30 days, or I have never been on ART.

AIMS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number and percentage of participants reinitiating late antiretroviral therapy (ART) prescription
Secondary outcome measures
Antiretroviral therapy (ART) adherence
Number and percentage of participants virally suppressed

AIMS Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
Usual Care participants will receive standard state-level care for missing ART prescription refill(s) for Virginia Medicaid enrollees with HIV.
Group II: AIMS program - patientExperimental Treatment1 Intervention
Participants will receive patient-level support. Support will come from the participant's provider, pharmacy, managed-care organization or the community.

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
697 Previous Clinical Trials
22,884,796 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,783 Previous Clinical Trials
2,688,949 Total Patients Enrolled
Virginia Department of Medical Assistance Services - Virginia MedicaidUNKNOWN

Media Library

Usual Care Clinical Trial Eligibility Overview. Trial Name: NCT05477485 — N/A
HIV/AIDS Research Study Groups: Usual Care, AIMS program - patient
HIV/AIDS Clinical Trial 2023: Usual Care Highlights & Side Effects. Trial Name: NCT05477485 — N/A
Usual Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05477485 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are adolescents eligible to enrol in this clinical trial?

"This medical study has set a minimum enrollment age of 19 and capped the maximum at 63, as laid out in its conditions for inclusion."

Answered by AI

Are there any participation opportunities for this research endeavor?

"According to the information provided on clinicaltrials.gov, this particular study is no longer considering applicants; it was initially posted in January of 2023 and last updated in November 2022. However, there are 636 other extant medical trials presently searching for participants."

Answered by AI

Am I eligible to become involved in this medical experiment?

"This clinical trial is seeking 1040 HIV-positive individuals, aged 19 to 63 and enrolled in Virginia Medicaid. Additional eligibility requirements include a continuous enrollment of at least 12 months prior, an identified history of living with HIV according to the prescribed algorithm, no dual Medicare eligibility, and evidence of either late ART prescription refills or lack thereof."

Answered by AI

Who else is applying?

What state do they live in?
Illinois
Virginia
How old are they?
18 - 65
What site did they apply to?
Virginia Commonwealth University
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Antiretroviral Improvement Among Medicaid Enrollees
2023. "Antiretroviral Improvement Among Medicaid Enrollees". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05477485.
~74 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top